Despite its expensive valuation and declining estimates, we suggest investors hold LLY stock as the company boasts solid ...

Novo Nordisk is doubling down on its oral drug strategy for obesity with a new partnership worth up to $2.2bn with Septerna.

A few years ago I switched this this CVS to the rite aid that used to be nearly because the pharmacist was rude. I ended up switching back in the past year because rite aid suddenly refused to ...